Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 91.07 USD 1.35% Market Closed
Market Cap: 134.2B USD
Have any thoughts about
Boston Scientific Corp?
Write Note

Boston Scientific Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Boston Scientific Corp
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Boston Scientific Corp
NYSE:BSX
Gross Profit
$11B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
Becton Dickinson and Co
NYSE:BDX
Gross Profit
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
8%
Edwards Lifesciences Corp
NYSE:EW
Gross Profit
$4.4B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Gross Profit
$14B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Gross Profit
$23B
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$5.3B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
14%
No Stocks Found

Boston Scientific Corp
Glance View

Market Cap
134.2B USD
Industry
Health Care
Economic Moat
Narrow

In the world of medical devices, Boston Scientific Corp. has carved out a significant niche, navigating the intersection of innovation and healthcare with precision. Founded in 1979, the company has built a robust reputation for developing a diverse range of products that address complex medical conditions. Boston Scientific operates through various segments, primarily focusing on interventional medical specialties that target areas such as cardiology, endoscopy, and neuromodulation. Through its relentless pursuit of innovation, the company continues to push boundaries, enhancing the diagnostic and therapeutic capabilities of physicians worldwide. The heartbeat of its operations lies in its extensive research and development endeavors, where cutting-edge technology meets advanced medical knowledge to produce life-enhancing solutions. At its core, Boston Scientific makes money by designing, manufacturing, and selling medical devices used in minimally invasive procedures. Its product portfolio includes solutions for coronary artery disease, heart rhythm disorders, peripheral artery disease, and many other critical ailments. By partnering with healthcare providers, Boston Scientific enables hospitals and clinics to offer high-quality, efficient care that caters to patient needs in a cost-effective manner. Revenue streams flow through direct sales channels and strategic partnerships across global markets, reflecting a combination of organic growth and strategic acquisitions. Moreover, the company actively reinvests in future technologies, ensuring its position as a pioneer in medical advancements while meeting the ever-evolving demands of the industry.

BSX Intrinsic Value
63.13 USD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Boston Scientific Corp's Gross Profit?
Gross Profit
11B USD

Based on the financial report for Sep 30, 2024, Boston Scientific Corp's Gross Profit amounts to 11B USD.

What is Boston Scientific Corp's Gross Profit growth rate?
Gross Profit CAGR 10Y
8%

Over the last year, the Gross Profit growth was 15%. The average annual Gross Profit growth rates for Boston Scientific Corp have been 13% over the past three years , 8% over the past five years , and 8% over the past ten years .

Back to Top